Mizuho Initiates Coverage On Medpace Hldgs with Buy Rating, Announces Price Target of $435
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Ann Hynes has initiated coverage on Medpace Holdings (NASDAQ:MEDP) with a Buy rating and set a price target of $435.
May 28, 2024 | 9:22 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mizuho analyst Ann Hynes has initiated coverage on Medpace Holdings with a Buy rating and set a price target of $435.
The initiation of coverage with a Buy rating and a high price target of $435 by a reputable analyst from Mizuho is likely to positively impact the stock price of Medpace Holdings in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100